Reply to the letter to the Editor “Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts”

被引：0
|
作者：
Nicolas Simon
Jean Claude Alvarez
机构：
[1] Aix-Marseille University,APHM, INSERM, IRD, SESSTIM, Hop Sainte Marguerite, Service de Pharmacologie Clinique, CAP
[2] Hôpitaux Universitaires Paris-Ile de France-Ouest,TV
[3] APHP,Département de Pharmacologie
[4] Hôpital Raymond Poincaré,Toxicologie
[5] FHU Sepsis,undefined
[6] MasSpecLab,undefined
[7] Plateforme de spectrométrie de masse,undefined
[8] Inserm U-1173,undefined
[9] Université Paris Saclay (Versailles Saint Quentin-en-Yvelines),undefined
来源：
European Journal of Clinical Pharmacology | 2021年 / 77卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：793 / 794
页数：1
相关论文
共 50 条
  • [1] Reply to the letter to the Editor "Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts"
    Simon, Nicolas
    Alvarez, Jean Claude
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (05) : 793 - 794
  • [2] Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts
    Cattaneo, Dario
    Corbellino, Mario
    Gervasoni, Cristina
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (05) : 791 - 792
  • [3] Prediction of lopinavir/ritonavir effectiveness in COVID-19 patients: a recall of basic pharmacology concepts
    Dario Cattaneo
    Mario Corbellino
    Cristina Gervasoni
    European Journal of Clinical Pharmacology, 2021, 77 : 791 - 792
  • [4] Letter to the Editor: Pharmacokinetics of Lopinavir/Ritonavir in Hospitalized Patients with COVID-19 Not Requiring Critical Care
    MacGowan, Alasdair
    Hamilton, Fergus
    Bayliss, Mark
    Read, Liam
    Attwood, Marie
    Noel, Alan
    Albur, Maha
    Grier, Sally
    Morley, Anna
    Arnold, David
    Maskell, Nicholas
    MICROBIAL DRUG RESISTANCE, 2022, 28 (05) : 611 - 612
  • [5] A Trial of Lopinavir-Ritonavir in Covid-19 Reply
    Cao, Bin
    Zhang, Dingyu
    Wang, Chen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (21):
  • [6] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Antonio Vitiello
    Francesco Ferrara
    Irish Journal of Medical Science (1971 -), 2021, 190 : 1249 - 1250
  • [7] Risk of bradycardia with lopinavir/ritonavir in COVID-19 patients
    Reactions Weekly, 2020, 1814 (1) : 9 - 9
  • [8] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Alvarez, Jean Claude
    Moine, Pierre
    Davido, Benjamin
    Etting, Isabelle
    Annane, Djillali
    Larabi, Islam Amine
    Simon, Nicolas
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2021, 77 (03) : 389 - 397
  • [9] Remdesivir versus ritonavir/lopinavir in COVID-19 patients
    Vitiello, Antonio
    Ferrara, Francesco
    IRISH JOURNAL OF MEDICAL SCIENCE, 2021, 190 (03) : 1249 - 1250
  • [10] Population pharmacokinetics of lopinavir/ritonavir in Covid-19 patients
    Jean Claude Alvarez
    Pierre Moine
    Benjamin Davido
    Isabelle Etting
    Djillali Annane
    Islam Amine Larabi
    Nicolas Simon
    European Journal of Clinical Pharmacology, 2021, 77 : 389 - 397
12345